IgorD. BandeiraMDPhD
Research • San Francisco, CAPostdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine
Dr. D. Bandeira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3550 Market St
San Francisco, CA 94131
Education & Training
Stanford UniversityPost-Doctoral Fellowship, 2021- Federal University of Bahia Faculty of MedicineDoctor of Philosophy, Clinical Neuroscience, 2019 - 2021
Federal University of Bahia Faculty of MedicineClass of 2018
Awards, Honors, & Recognition
- New Investigator Award International Society for CNS Clinical Trials and Methodology, 2025
- Alies Muskin Career Development Leadership Program Award Anxiety and Depression Association of America, 2025
- Travel Fellowship Award Winter Conference on Brain Research, 2025
- Join now to see all
Clinical Trials
- Opiate Suicide Study in Patients With Major Depression Start of enrollment: 2020 Aug 01
- Personalized Therapeutic Neuromodulation for Anhedonic Depression Start of enrollment: 2022 May 31
- Rapid Acting TMS for Suicide Ideation in Depression Start of enrollment: 2021 Nov 07
- Join now to see all
Publications & Presentations
PubMed
- Early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression.David Benrimoh, Azeezat Azeez, Jean-Marie Batail, Xiaoqian Xiao, Derrick Buchanan
Npj Mental Health Research. 2024-10-28 - 1 citationsEsketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, Igor D Bandeira, Daniela Faria-Guimarães
Clinical Neuropharmacology. 2024-01-02 - 5 citationsDoes the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secon...Mariana V F Echegaray, Rodrigo P Mello, Guilherme M Magnavita, Gustavo C Leal, Fernanda S Correia-Melo
Trends in Psychiatry and Psychotherapy. 2023-09-17
Other Languages
- Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
